Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pyrrolopyrimidine ketone compound and preparation method and application thereof

A technology of pyrrolopyrimidones and compounds, applied in the field of pyrrolopyrimidones and their preparation, capable of solving problems such as cardiovascular pathological reactions, hypoglycemia, and β-cell death

Inactive Publication Date: 2017-06-20
GUANGZHOU INST OF BIOMEDICINE & HEALTH CHINESE ACAD OF SCI
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Promoting the secretion of insulin by pancreatic β-cells is the main method for the treatment of T2DM, but the traditional hypoglycemic drugs insulin sensitizers (such as biguanides, thiazolidinediones, etc.) and insulin secretagogues (such as sulfonylureas and non-sulfonylureas At the same time of treatment, it often leads to side effects such as hypoglycemia, weight gain, cardiovascular morbidity and β-cell death

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pyrrolopyrimidine ketone compound and preparation method and application thereof
  • Pyrrolopyrimidine ketone compound and preparation method and application thereof
  • Pyrrolopyrimidine ketone compound and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0114] Example 1. Synthesis of Compound 1.

[0115]

[0116] Proceed according to the following synthetic route:

[0117]

[0118] 1) Synthesis of compound 1-1:

[0119] Add 520ml of concentrated sulfuric acid into a 100mL eggplant-shaped bottle, add 140g of 6-methyluracil in batches under ice-cooling, and keep the temperature not exceeding 40°C. After it is completely dissolved, slowly add 104ml of fuming nitric acid dropwise, keeping the temperature not exceeding 15°C. After the dropwise addition was completed, after stirring at room temperature for 30 min, the reaction solution was poured into crushed ice, and solids were washed out. After suction filtration, the filter cake was washed with water and acetone and then dried to obtain the target compound 1-1.

[0120] 1H-NMR (400 MHz, DMSO-d6): δ 11.79 (1H, s), 11.76 (1H, s), 2.28 (3H, s).

[0121] 2) Synthesis of compound 1-2:

[0122] Add 119g of compound 1-1 and 400mL of N,N-dimethylformamide into a 1000mL two-nec...

Embodiment 2

[0142] Embodiment 2. Synthesis of compound 2

[0143]

[0144] Proceed according to the following synthetic route:

[0145]

[0146] 1) Synthesis of compound 2-1:

[0147] Compound 1-7 (303 mg, 1.0 mmol) was dissolved in 20 mL of THF, 60% sodium hydrogen (48 mg, 1.2 mmol) was added under nitrogen protection at 0°C, stirred until no gas was generated, and methanesulfonyl chloride (137 mg, 1.1 mmol), gradually raised to room temperature and stirred for 5 hours, the reaction solution was added with 50mL of water, then extracted with 3×80mL of ethyl acetate, the organic layers were combined, washed successively with saturated aqueous sodium bicarbonate solution, water and saturated brine, anhydrous sodium sulfate Drying, separation by flash column chromatography to obtain compound 2-1 with a yield of 88%;

[0148] MS: 381.0 [M+H + ].

[0149] 2) Synthesis of compound 2:

[0150] Compound 2-1 obtained in the above steps was used as a raw material, and compound 2 was synt...

Embodiment 3

[0152] Embodiment 3. Synthesis of compound 3

[0153]

[0154] Proceed according to the following synthetic route:

[0155]

[0156] Using compound 1-7 as raw material, 2-cyano-5-fluorobenzyl bromide was used instead of methanesulfonyl chloride, referring to the synthesis method of Example 2, compound 3 was synthesized with a yield of 53%;

[0157] MS: 500.2 [M+H + ].

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Resistanceaaaaaaaaaa
Login to View More

Abstract

The invention relates to a pyrrolopyrimidine ketone compound and a preparation method and application thereof, and belongs to the technical field of medicine. The pyrrolopyrimidine ketone compound having a structural feature of formula I, or a pharmaceutically acceptable salt thereof has a very good inhibition effect on DPP-IV, and almost no effect on activity of DPP-VIII and DPP-IX, can effectively control the blood glucose concentration of diabetic rats, and is safe and low in toxicity through the verification of pharmacological and toxicological tests. After being prepared into a medicine, the compound provided by the invention not only has an obvious efficacy but also has very small side effects, thus greatly improving the administration convenience and patient use compliance, therefore, the compound has obvious advantages compared with the same kind of medicine. The formula is shown in the specification.

Description

technical field [0001] The present invention relates to the technical field of medicine, in particular to a pyrrolopyrimidinone compound and its preparation method and application. Background technique [0002] Diabetes mellitus is caused by absolute or relative lack of insulin, resulting in elevated blood sugar, which can lead to serious complications and eventually lead to disability or death of the patient. Clinically, diabetes is divided into type 1 and type 2. Type 1 diabetes is due to the destruction of pancreatic β-cells and lack of insulin secretion, which leads to elevated blood sugar. Such patients can only rely on exogenous insulin; type 2 diabetes is caused by relatively insufficient insulin secretion or imperfect insulin action Hyperglycemia, its incidence rate accounts for more than 90% of all diabetic patients. Current drug research is mainly aimed at type 2 diabetes mellitus (T2DM). [0003] Promoting the secretion of insulin by pancreatic β-cells is the m...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D487/04A61K31/519A61P3/10A61P3/04
CPCC07D487/04
Inventor 胡文辉曾少高张桂成
Owner GUANGZHOU INST OF BIOMEDICINE & HEALTH CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com